The UK government is preparing to make nearly £43bn

New Post Public Reply Private Reply Replies (1) Message Board
trevorbc
558

The UK government is preparing to make nearly £43bn available to companies that can help deliver on its mass Covid-19 testing vision, which aims to roll out rapid turnround tests across the country.

Private and public sector organisations are being invited to apply for three tenders for the supply of new testing technologies as part of prime minister Boris Johnson’s so-called “Project Moonshot” testing programme.

It is anticipated that hundreds of companies will apply to supply products and services to the government as part of the open procurement process.


One tender worth £22bn, released by Public Health England last week, is open to companies that make different testing equipment, including medical devices and “a range of clinical laboratory diagnostic testing services”. It will last for two years, with the option to extend for two more.

Another tender notice released by NHS Supply Chain — which manages the sourcing, delivery and supply of healthcare products — covers the provision of so-called point-of-care tests and diagnostics equipment. The value of the tender has been lifted from £5bn to £20bn “due to the pandemic situation resulting in an immediate overall increased spend in support of [the] Covid-19 testing programme”.

Although a specific time period is not mentioned, the NHS tender stipulates that “these contracts are likely to be multiyear”.

Latest coronavirus news

Follow FT's live coverage and analysis of the global pandemic and the rapidly evolving economic crisis here.

Together, the two tenders are worth more than three times the total spent on police in England and Wales in 2018-19.

Last week, Liverpool became the first city in the UK to trial mass population testing, although the ambitious plan to test the entire population for coronavirus over 14 days is struggling to scale up quickly, suggesting it may have to be extended.


The PHE tender does not specifically mention coronavirus. However, executives at companies that manufacture and supply Covid-19 testing equipment told the Financial Times they had been invited to apply “to support all five pillars of the UK testing strategy”.

The Department of Health and Social Care said: “As part of an unprecedented response to this global pandemic, we have drawn on the expertise and resources of a number of public and private sector partners to support our testing programme.”

The figures represented a maximum value, and not necessarily the final amount that would be spent, the DHSC said.

Meanwhile, a third tender, covering a much shorter period of just three-and-a-half months and published on Monday, offered £912m for the supply of lateral flow tests, which give results in between 10 and 30 minutes. Lateral flow tests cost in the range of £5 to £30 each, meaning this sum could potentially buy the government more than enough devices to test the entire population once.

Companies have a total of four days to respond to the third tender, “due to the current state of urgency faced by the authority in implementing measures to deal with the Covid-19 pandemic”. The other two tenders gave a one-month deadline.

In September, the campaign group, the Good Law Project, launched a judicial review against the government’s Project Moonshot, claiming it was an “initiative involving the intention to spend c. £100bn of public money on a new, mass population Covid-19 testing programme providing 6-10m tests a day”.

Although the government issued a legal response at the time claiming that “no financial commitment has been entered into approaching anything like that sum”, the maximum value of the tender agreements published in the past few days would come to a sum worth just under half that figure.

Recommended
Azra Ghani
Does a vaccine against Covid-19 herald the end of the pandemic?
Point-of-care tests, which give results at the same point they are administered, are considered the government’s best bet for ramping up testing. Some use the lateral flow technology, where a saliva or swab sample is put into a well, a liquid reagent is added and a line appears in a window indicating positive or negative.

Following Pfizer and BioNTech’s positive vaccine results, published on Monday, some have questioned whether a mass-testing programme remains necessary. But experts have reiterated that population-wide repeat testing will be the only viable route to increased socialisation in the coming months.

According to available public contracts, the government has so far spent close to £1bn on lateral flow tests, exclusively from companies outside of the UK.

This includes £634m on millions of tests produced by US company Innova, which are manufactured in China, £159m on tests produced by US group Tanner Pharma, £120bn on products from US pharma giant Abbott and £32.3m on tests produced by LumiraDx, which are also being offered by the pharmaceuticals retailer Boots.

Innova’s lateral flow tests form the backbone of the government’s population-wide testing pilot in Liverpool, though it is also being supplemented by so-called “Lamp” technology and the gold-standard PCR tests, which use polymerase chain reaction technology. 

The government has also spent an unspecified sum on lateral flow tests produced by the Chinese company Zhejiang Orient Gene and the South Korean company SD Biosensor, though it has not released public contracts for either of these.

Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Avoid FOGs: Illinois Water's Holiday PSA

Updated Category News Views 112

Don't Ignore the Kitchen Sink This Holiday You ever poured something down the drain and just prayed it wouldn't come back to bite you later? Well, Illinois American Water is throwing up a big, red flag about doing exactly that during the holidays. When we're all busy passing the gravy boat and diving into festive feasts, it's easy to forget the after-party might just turn...

Continue Reading
Panduit's AI Cooling Lab Boosts Data Center Innovation

Updated Category News Views 140

Innovation in Cooling: Panduit's Latest Move You hear "AI" and "data center" together and you know it's not gonna be business as usual. Here's Panduit throwing another log on the fire with their newly minted AI Cooling Lab. Panduit's a big cheese in the electrical and network infrastructure world. They've taken their Thermal Lab, given it a face-lift, and now, they’re...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 163

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading
CSMI Boosts CT's Cybersecurity for Defense Sector

Updated Category News Views 109

Paving the Way for Cybersecurity Excellence Out in chilly Connecticut, CSMI made a mark. The State's Office of Manufacturing picked them to join the advisory council for the Defense CyberSecure Program (CT-DCP). It ain’t just a pat on the back; it's a big deal for the region's defense and aerospace manufacturing gang. Connecticut's got its eyes set on beefing up its...

Continue Reading
Intel Faces Class Action Over Alleged Securities Fraud

Updated Category News Views 122

Intel's Legal Predicament: Decoding the Lawsuit Saddle up, folks, because Intel (NASDAQ: INTC) has found itself tangled in legal vines again. This ain't their first rodeo, and probably won't be their last. We're looking at a hefty class action lawsuit rallying on claims that Intel misled investors with optimistic yarns about their health. SBS Law, waving the litigation...

Continue Reading
Chicago Auto Show: Run & Explore Indoors This February

Updated Category News Views 136

Nobody’s thinking about running laps when they walk into a colossal auto show, but the Chicago Auto Show isn't letting the pedal ease off the gas. Swing by on February 14, folks, for something not typically seen on the floors of McCormick Place. Run participants have got one hour to log as many miles as they can on the 2.4-mile loop right inside the show. Why a Running...

Continue Reading
Radiotherapy Suit Challenges New EviCore Guidelines

Updated Category News Views 100

Turning Up the Heat on EviCore Winter Park, Florida—home of sunshine, oranges, and now a heated legal standoff. On November 16, 2026, the Radiotherapy Access Alliance dropped a bombshell lawsuit against EviCore over its recent guideline flip-flop. EviCore reversed its stance on low-dose radiation therapy (LDRT) for arthritis and other pesky pain, leaving patients—and...

Continue Reading
Main Capital Partners Backs TaskRay: Salesforce Expansion

Updated Category News Views 111

Investing in Transformation Main Capital Partners has thrown in with TaskRay, joining hands with Cloud Coach and JustOn to shake up customer delivery on Salesforce. These three are cooking up an ambitious AI-driven platform that's gunning to streamline from project management to financial operations. Main's stepping into this mix with a mindset that aligns with over 800...

Continue Reading
equipifi's BNPL Shop: New Ammo for Credit Unions

Updated Category News Views 106

equipifi's 'Shop': The Big Play in Banking Look, here’s the deal—equipifi just lobbed a new grenade into the finance battlefield, arming credit unions and community banks with 'Shop', their own Buy Now, Pay Later (BNPL) platform. The goal? To put them toe-to-toe with the big fintech wolves—something these smaller guys desperately needed. It's a meaty move, no...

Continue Reading
Kinross Gold Fraud Lawsuit: What Shareholders Need to Know

Updated Category News Views 58

Kinross Gold's Legal Quagmire There's a fresh storm brewing for Kinross Gold Corporation (NYSE: KGC), and it ain't the kind investors enjoy riding. You see, the company is up to its neck in a class action lawsuit, courtesy of Schall, Brown & Schwartz LLP—a big-name shareholder rights litigation outfit. The gripe? Alleged securities fraud, violating §§10(b) and 20(a)...

Continue Reading

Top 5 Most Recently Viewed Articles

SiriusPoint Declares Cash Dividend on Series B Preference Shares

Updated Category News Views 123

SiriusPoint Declares Quarterly Cash Dividend for Investors In a significant move for its shareholders, SiriusPoint Ltd. has recently revealed the approval of a quarterly cash dividend of $0.50 per share for the 8.00% Resettable Fixed Rate Preference Shares, Series B. This decision, endorsed by the Audit Committee of the Board of Directors, showcases the company's...

Continue Reading
Urban One Welcomes New Leadership as CEO David Kantor Retires

Updated Category News Views 435

Changes in Leadership at Urban One Urban One has made a significant announcement regarding changes at the helm of its audio division. Currently, the company bids farewell to CEO David Kantor, a well-respected figure in the industry, whose tenure has shaped Urban One into a key player in audio entertainment. Kantor's retirement, set for early 2025, opens the door for new...

Continue Reading
Mattamy Homes Expands Presence with New Division in Florida

Updated Category News Views 502

Mattamy Homes Expands Operations in Florida Company strengthens regional focus to enhance customer service, empower teams and drive future expansion Mattamy Homes US has officially launched a new division centered in Southwest Florida. This strategic initiative is set to improve operational agility, allowing Mattamy to provide exceptional service to its customers...

Continue Reading
Eloro Resources Secures $3.78 Million in Latest Placement

Updated Category News Views 235

Eloro Resources Completes Private Placement Successfully Eloro Resources Ltd. (TSX: ELO; OTCQX: ELRRF; FSE: P2QM) has announced a significant achievement in its funding efforts. The company successfully closed its non-brokered private placement offering, concluding with a total of 4,200,000 units sold. This move resulted in gross proceeds of approximately $3,780,000,...

Continue Reading
Groundbreaking Global Health Exhibition Set to Transform Healthcare

Updated Category News Views 54

Global Health Exhibition Promises Unmatched Innovation Tomorrow marks the opening of the much-anticipated Global Health Exhibition, an international healthcare event attracting over 100,000 professionals dedicated to health and patient care. Spanning across three days, this premier event will host an impressive assembly of over 1,200 exhibiting companies and brands,...

Continue Reading